Methods of treatment of cholestatic diseases
US12053445B2 · kind B2 · utility
6Cited by
6References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 23, 2021 |
| Grant date | Aug 6, 2024 |
| Priority date | — |
| Expiry date | Dec 15, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of compound 1-[4-methylthiophenyl]-3-[3,5-dimethyl-4-carboxydimethylmethyloxyphenyl]prop-2-en-1-one (Elafibranor or GFT505) for treating cholestatic diseases, and more specifically PBC and/or PSC.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.